HK1021511A1 - Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug - Google Patents

Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Info

Publication number
HK1021511A1
HK1021511A1 HK00100533A HK00100533A HK1021511A1 HK 1021511 A1 HK1021511 A1 HK 1021511A1 HK 00100533 A HK00100533 A HK 00100533A HK 00100533 A HK00100533 A HK 00100533A HK 1021511 A1 HK1021511 A1 HK 1021511A1
Authority
HK
Hong Kong
Prior art keywords
fast
granulate
disintegrating
drug
preparation
Prior art date
Application number
HK00100533A
Other languages
English (en)
Inventor
Bernardus Leonardus Dijkgraaf
Aart Muhlenbruch
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8224133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1021511(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of HK1021511A1 publication Critical patent/HK1021511A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
HK00100533A 1996-07-03 2000-01-28 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug HK1021511A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96201829 1996-07-03
US08/770,421 US5837292A (en) 1996-07-03 1996-12-20 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
PCT/EP1997/003250 WO1998001114A1 (fr) 1996-07-03 1997-06-19 Granules destines a la preparation de compositions a haut pouvoir de desintegration et de dissolution, a teneur elevee en medicament

Publications (1)

Publication Number Publication Date
HK1021511A1 true HK1021511A1 (en) 2000-06-16

Family

ID=8224133

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100533A HK1021511A1 (en) 1996-07-03 2000-01-28 Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug

Country Status (36)

Country Link
US (1) US5837292A (fr)
EP (1) EP0910344B1 (fr)
JP (1) JP4159607B2 (fr)
CN (1) CN1131025C (fr)
AR (1) AR008252A1 (fr)
AT (1) ATE237314T1 (fr)
AU (1) AU731276B2 (fr)
BG (1) BG64114B1 (fr)
BR (1) BR9710181B1 (fr)
CA (1) CA2258841C (fr)
CO (1) CO4890859A1 (fr)
CZ (1) CZ295893B6 (fr)
DE (1) DE69720995T2 (fr)
DK (1) DK0910344T3 (fr)
EA (1) EA001537B1 (fr)
EG (1) EG23814A (fr)
ES (1) ES2197351T3 (fr)
HK (1) HK1021511A1 (fr)
HU (1) HU225115B1 (fr)
ID (1) ID17128A (fr)
IL (1) IL127364A (fr)
JO (1) JO1969B1 (fr)
MY (1) MY116124A (fr)
NO (1) NO320767B1 (fr)
NZ (1) NZ333247A (fr)
PE (1) PE89798A1 (fr)
PL (1) PL188235B1 (fr)
PT (1) PT910344E (fr)
SI (1) SI0910344T1 (fr)
SK (1) SK284175B6 (fr)
TN (1) TNSN97114A1 (fr)
TR (1) TR199802762T2 (fr)
TW (1) TW473392B (fr)
UA (1) UA61917C2 (fr)
WO (1) WO1998001114A1 (fr)
ZA (1) ZA975848B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129932A (en) * 1997-09-05 2000-10-10 Merck & Co., Inc. Compositions for inhibiting platelet aggregation
DE19820801A1 (de) * 1998-05-09 1999-11-25 Gruenenthal Gmbh Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
US6177101B1 (en) 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
EP1180022A4 (fr) * 1999-05-14 2004-01-07 Lilly Co Eli Elaboration d'un produit pharmaceutique en vrac uniformement dissout
HU227070B1 (en) * 1999-08-11 2010-06-28 Egis Gyogyszergyar Nyilvanosan Immediate release pharmaceutical composition containing ciprofloxacin and process for its production
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
FR2816507B1 (fr) * 2000-11-16 2003-02-28 Ethypharm Lab Prod Ethiques Microgranules a base de principe actif, procede de fabrication et compositons pharmaceutiques integrant lesdits microgranules
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
JP2004522752A (ja) * 2001-02-05 2004-07-29 アール．ピー． シェーラー テクノロジーズ インコーポレイテッド 薬学的活性剤の味を軽減するための方法および組成物
EP1285649A1 (fr) * 2001-08-23 2003-02-26 Cimex AG Comprimé dispersible à deux couches comprenant de l'amoxicilline et du clavulanate dans des couches séparées
BR0307516A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Formas de dosagem de liberação imediata contendo dispersões de uma droga sólida
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
WO2004006917A1 (fr) * 2002-07-16 2004-01-22 Ranbaxy Laboratories Limited Comprimes dispersibles pour administration par voie orale
WO2004014337A2 (fr) * 2002-08-02 2004-02-19 Ranbaxy Laboratories Limited Procede de preparation d'un comprime dispersible de cephalexine
JP4702763B2 (ja) * 2003-07-30 2011-06-15 塩野義製薬株式会社 結晶セルロースを含有する安定な錠剤
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
ES2655435T3 (es) * 2003-09-12 2018-02-20 Amgen Inc. Formulación de disolución rápida de cinacalcet
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
EP1681050A1 (fr) * 2005-01-13 2006-07-19 Strides Arcolab Limited Composition pharmaceutique dispersible avec libération prolongée
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
WO2008008120A1 (fr) * 2006-07-14 2008-01-17 Fmc Corporation Forme solide
JP5201819B2 (ja) * 2006-11-22 2013-06-05 エスエス製薬株式会社 固形組成物
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
ES2758624T3 (es) * 2009-02-12 2020-05-06 Fuji Chem Ind Co Ltd Composición de partículas desintegrantes y material de desintegración rápida moldeado por compresión que comprende la misma
EP2575777A1 (fr) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
WO2013151517A1 (fr) * 2012-04-04 2013-10-10 Mahmut Bilgic Formulations en comprimés comprenant du cefpodoxime proxétil et de l'acide clavulanique
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN106255512B (zh) 2014-04-21 2021-01-01 株式会社大赛璐 含有微小纤维状纤维素的崩解性颗粒组合物
CN110051639B (zh) * 2019-03-15 2021-08-31 河北嘉迈医药科技有限公司 一种快速崩解型尼麦角林片及其制备方法
CN117683469A (zh) * 2023-10-24 2024-03-12 绍兴拓邦新能源股份有限公司 一种晶硅片背面碱抛光固态添加剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1322306A (en) * 1971-04-15 1973-07-04 Meiji Seika Co Stabilized antibiotic preparation and manufacturing process therefor
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
GB1509866A (en) * 1975-06-10 1978-05-04 Johnson & Johnson Enteric coated digestive enzyme compositions
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
NL184308C (nl) * 1975-07-24 1989-06-16 Takeda Chemical Industries Ltd Werkwijze voor het bereiden van l-ascorbienzuurgranules.
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
EP0200252B1 (fr) * 1985-05-02 1999-03-10 Yamanouchi Europe B.V. Comprimés contenant de la triméthoprime et un sulfonamide
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
EP0281200B1 (fr) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Composition pharmaceutique, granulé pharmaceutique et leur procédé de fabrication
DE68916983T2 (de) * 1988-02-25 1995-01-19 Yamanouchi Europ Bv Verfahren zur Herstellung eines pharmazeutischen Granulats.
US4911921A (en) * 1989-02-02 1990-03-27 Mallinckrodt, Inc. High ibuprofen content granulations
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
IL109097A0 (en) * 1993-04-03 1994-06-24 Knoll Ag Delayed release micro tablet of beta-phenylpropiophenone derivatives and its production

Also Published As

Publication number Publication date
HUP9903308A2 (hu) 2000-03-28
TNSN97114A1 (fr) 2005-03-15
BG64114B1 (bg) 2004-01-30
HUP9903308A3 (en) 2001-03-28
ATE237314T1 (de) 2003-05-15
EA001537B1 (ru) 2001-04-23
SK176798A3 (en) 2000-04-10
NO986157L (no) 1999-02-01
SI0910344T1 (en) 2003-08-31
BR9710181B1 (pt) 2009-08-11
ES2197351T3 (es) 2004-01-01
BG103047A (en) 1999-07-30
HU225115B1 (hu) 2006-06-28
EA199900075A1 (ru) 1999-06-24
EG23814A (en) 2007-09-12
NO320767B1 (no) 2006-01-23
AU731276B2 (en) 2001-03-29
JP4159607B2 (ja) 2008-10-01
PT910344E (pt) 2003-09-30
DE69720995T2 (de) 2003-11-13
NO986157D0 (no) 1998-12-28
BR9710181A (pt) 1999-08-10
CA2258841A1 (fr) 1998-01-15
AU3342197A (en) 1998-02-02
IL127364A0 (en) 1999-10-28
PE89798A1 (es) 1999-01-12
EP0910344A1 (fr) 1999-04-28
MY116124A (en) 2003-11-28
CZ699A3 (cs) 1999-04-14
WO1998001114A1 (fr) 1998-01-15
AR008252A1 (es) 1999-12-29
TR199802762T2 (xx) 1999-03-22
CA2258841C (fr) 2006-05-30
JP2000513727A (ja) 2000-10-17
JO1969B1 (en) 1997-12-15
SK284175B6 (sk) 2004-10-05
UA61917C2 (uk) 2003-12-15
ID17128A (id) 1997-12-04
US5837292A (en) 1998-11-17
CZ295893B6 (cs) 2005-11-16
ZA975848B (en) 1999-04-12
CN1131025C (zh) 2003-12-17
PL330958A1 (en) 1999-06-21
NZ333247A (en) 2000-07-28
PL188235B1 (pl) 2004-12-31
TW473392B (en) 2002-01-21
CO4890859A1 (es) 2000-02-28
IL127364A (en) 2003-04-10
CN1224348A (zh) 1999-07-28
DE69720995D1 (de) 2003-05-22
EP0910344B1 (fr) 2003-04-16
DK0910344T3 (da) 2003-07-07

Similar Documents

Publication Publication Date Title
IL127364A0 (en) Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL116460A0 (en) Aerosol drug formulations
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
IL115039A (en) Spiroazabicyclic compounds, their preparation and pharmaceutical compositions containing them
AP9500733A0 (en) Pharmaceutical formulations
IL119995A0 (en) Pyrido-fused thienyl - and furanyl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL135366A0 (en) Substituted benzoxazoles and pharmaceutical compositions containing the same
GB9404248D0 (en) Pharmaceutical formulations
HUP9801995A3 (en) Substituted pyrimidine-thioalkyl and alkylether compounds and their use for producing pharmaceutical compositions
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
EP0803255A4 (fr) Composition medicinale
IL112443A0 (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
HU9500618D0 (en) Oral pharmaceutical compositions
IL117629A0 (en) Pharmaceutical compositions containing a benzamide derivative and methods for the preparation thereof
CY2293B1 (en) Slow-release pharmaceutical formulations containing mizolastin
IL115981A0 (en) Cyclolignan derivatives procosses for the preparation thereof and pharmaceutical compositions containing the same
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
IL115853A (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds
IL128917A0 (en) New heteroaryloxyethylamines a process for the preparation thereof their use as medicaments and pharmaceutical compositions containing them
GB9418550D0 (en) Drug formulation
GB9413542D0 (en) Pharmaceutical formulations
ZA9510754B (en) Aerosol drug formulations
GB9401638D0 (en) New medicinal compositions of matter

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20170618